mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.24 |
9e-10 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
-0.24 |
2e-09 |
mRNA |
Panobinostat |
CTRPv2 |
pan-cancer |
AAC |
-0.23 |
3e-08 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
1e-07 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
3e-07 |
mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
7e-07 |
mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
-0.24 |
3e-06 |
mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
-0.27 |
4e-06 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
4e-06 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
5e-06 |